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                                                  Abstract 
 
 
Different solid phase modifications were studied in order to develop new and simple 
routes for  pharmaceutically interesting highly substituted carboxyindoles. A 
convenient method for the preparation of 5-substituted 2-carboxyindoles and three 
novel direct functionalization methods for carboxyindoles were developed during this 
study. 
5-Nitro-2-carboxyindole was synthesized easily in three steps from commercially 
available inexpensive 4-nitro-aniline. Through attachment of this template to solid 
phase followed by reduction, reductive amination, N-alkylation and cleavage, a small 
library of differently substituted carboxyindoles were obtained. 
Solid phase brominations were studied followed by palladium catalyzed Suzuki-
coupling. This technology offers an efficient and selective method to introduce 
bromine and a new C-C-bond to 3-position of polymer bound 2-carboxyindoles. 
Formylation studies were also succesfull. By utilizing Vilsmeier formylation a new C-
C-bond was obtained direcly and selectively at the 3-position of polymer bound 2-
carboxyindoles. 
In solid phase metalation studies of 5-carboxyindoles a 4-position functionalization 
was achieved in 80 % regioselectivity. Despite the moderate regioselectivity it is 
obvious that ring lithiation can be adopted to solid phase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 
 
Research work reported in this thesis has been carried out in the Department of 
Pharmaceutical Chemistry at the University of Helsinki during the years 1998-2001 
under the guidance of Professor Robert Franzén and in the Department of Chemistry 
at the Helsinki University of Technology during the years 2001-2003 under the 
guidance of Professor Ari Koskinen. 
First I wish to thank my supervisor, Professor Ari Koskinen, for offering me the 
possibility to work in his group and providing his expertise in organic synthesis. His 
encouraging comments and helpful attitude towards my work has been extremely 
valuable during these years. Great thanks belongs also to my supervisor at the first 
years, Professor Robert Franzén. Thank you for your kind attitude and valuable hints 
in the early stages of this work. 
Special thanks go to the people who have shared the laboratory with me. You have all 
encouraged me during these, not always so pleasant, years. Thank you Mikko, Antti, 
Mika, Petteri, Olli and Irene for standing on my side in difficult moments. Thank you 
all at the Helsinki University of Technology, Laboratory of Organic Chemistry and 
especially Markku. 
I would like to thank my parents and my father-in-law for their support during my 
studies. You have always remined me by asking: “ What is the current status of your 
thesis? “. 
The last and the warmest thanks belong to my loving wife Eva. You are probably the 
only person who believed all the time that I will finally managed to do this thesis. At 
the moments I my self had some misbelief your belief was stronger. Thank you Eva. 
 
 
 
Espoo, April 2003                                                              Jan Tois 
 
 3
 
Ac acetyl 
AIBN azobis(isobutyronitrile) 
Ar aryl 
Bn benzyl 
BINAP 2,2’-bis(diphenylphosphino)-1,1’-binaphtyl 
Boc t-butoxycarbonyl 
Bu butyl 
dppf 1,1’-bis(diphenylphosphino)ferrocene 
DBU 1,8-diazabicyclo[5.4.0.]undec-7-ene 
dba dibenzylideneacetone 
DCA dichloroacetic acid 
DCE dichloroethane 
DCM dichloromethane 
DCC dicyclohexylcarbodiimide 
DEM dimethoxymethyl 
DIC di-isopropylcarbodiimide 
DIPEA di-isopropylethylamine 
DME 1,2-dimethoxyethane 
DMA N,N-dimethylacetamide 
DMAP 4-N,N-dimethylaminopyridine 
DMF N,N-dimethylformamide 
Et ethyl 
EtOAc ethylacetate 
Fmoc fluorenylmethoxymethyl 
HPLC high-performance liquid chromatography 
HOBt 1-hydroxybenzotriazole 
HMB hydroxymethylbenzoic acid 
MSNT 1-(2-mesitylene-sulfonyl)-3-nitro.1,2,4-triazole 
Me methyl 
NBS N-bromosuccinimide 
NIS N-chlorosuccinimide 
NMFA N-methylformanilide 
NMI N-methylimidazole 
NMP 1-methyl-2-pyrrolidine 
PPA polyphosphoric acid 
PS polystyrene 
PKC protein kinace C 
PBP pyridinium bromide perbromide 
SPOS solid phase organic chemistry 
SPPS solid phase peptide synthesis 
TBAF tetrabutylammonium fluoride 
THF tetrahydrofuran 
TMG 1,1,3,3-tetramethylguanidine 
TLC thin layer chromatography 
Ts tosyl, p-toluenesulfonyl 
TEA triethylamine 
TFA trifluoroacetic acid 
TIPS tri-isopropylsilyl 
TMOF trimethylorthoformate 
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                                             1. Introduction 
 
                                             1.1. Introduction to indoles 
 
Indole 1 is a benzopyrrole in which the benzene and pyrrole rings are fused through 
the 2, 3-positions of the pyrrole. 
 
 
 
 
 
 
 
Figure 1. The basic structure and numbering system of indole compounds. 
 
Indole is a colorless crystalline solid (mp 52-54 oC, bp 254 oC) with an unpleasant 
odour. It is classified as an π-excessive aromatic heterocyclic compound, with the 
heterocyclic nitrogen atom donating two of the ten π-electrons. Resonance structures 
are illustrated in Figure 2. 
 
 
 
 
 
 
 
 
Figure 2. Resonance structures of indole. 
 
Indole derivatives occur widely in many natural products. Indole itself has been 
obtained in small amounts by extraction from naturally occurring materials by 
methods which suggest that the indole so obtained is in many cases the result of 
breakdown of its derivatives. Various plants have yielded indole, among them the 
following: Robinia pseudacacia,1 the jasmines, 2, 3, 4 certain citrus plants, 5 and orange 
blossoms.6 Indole is also found after putrefactive processes have taken place. It is 
found in the animal body wherever pus formation occurs 7 and in the liver 8 and 
brain.9 Indole has also been found to be present in coal tar in the fraction boiling 
between 240 o - 260 oC.10 In 1930 it was discovered that the essential amino acid, 
tryptophan 4 was in fact an indole derivative. 
 
 
 
 
 
 
 
 
Figure 3. Amino acid (S)-tryptophan. 
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                                     1.2. Indole alkaloids 
 
The alkaloids are a group of naturally occurring organic compounds containing 
nitrogen. The term alkaloid means simply alkalilike. The first modern definition was 
presented by Winterstein and Trier.11 “ True alkaloids “ were defined as compounds 
meeting four additional qualifications: 
 
1. The nitrogen atom is part of a heterocyclic system. 
2. The compound has a complex molecular structure 
3. The compound manifests significant pharmacological activity. 
4. The compound is restricted to the plant kingdom. 
 
Nowadays a more simple definition has been suggested:12 
 
An alkaloid is a cyclic organic compound containing nitrogen in a negative oxidation 
state which is of limited distribution among living organisms. 
 
The chemical classification of alkaloids is based on their carbon-nitrogen skeletons 
and some of the commonest skeletons are shown below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Some common alkaloid ring skeletons. 
 
The alkaloids containing an indole nucleus are an extensive and complex group of 
compounds. It has been estimated that more than one-quarter of all known alkaloids 
are indole derivatives.13 While the distribution of indole alkaloids is broad, certain 
plant groups are noted for containing them. Seed plant family Apocynaceae has been 
well-investigated 14 and also the fungal genus Claviceps (ergot) is an important source 
of indole alkaloids.15  
Usually the indole alkaloids are complex molecules and optically active. Some well-
known indole alkaloids are presented in Figure 5.  
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Figure 5. Some well-known indole alkaloids. 
 
Most of the indole alkaloids are derived from the amino acid (S)-tryptophan 4 and the 
aminoethyl side chain at the 3-position is still discernible in their structures. 
 
1.3. Physiologically active indole derivatives 
 
There are several thousand indole alkaloids known and many of these have important 
physiological activity.16 Ergotamine 7 is a potent vasoconstrictor and is used, as its 
tartrate salt, to treat migraine.17 Reserpine 5 has been used to treat hypertensive, 
nervous and mental disorders.18 Even though most indole related compounds are 
complex structures, simple indole derivatives also exist in nature. Psilocin 9 is one of 
the active constituents of Mexican mushrooms which have been used as early as 1500 
BC in Aztec and Mayan culture as hallucinogens.19 Bufotenine 10 is another 
hallucinogen that occurs in toadstool.20 Serotonin 11 is widely distributed in nature 
and it acts as a constrictor of arteries in brain and is implicated in migraine.21  
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Figure 6. Psilocin  9, Bufotenine 10 and serotonin 11. 
 
Since the discovery of sumatriptan 12 22 (a 5-HT1B/1D receptor agonist, used as an 
effective treatment for migraine headache) intensive research in this area 23-28 has led 
to several related compounds such as naratriptan 13,29 zolmitriptan 14,30 rizatriptan 15 
31 and eletriptan 16 32 entering the market and late phase clinical trials. L-772, 405 17 
33 also shows very good selectivity over a range of other serotonin and nonserotonin 
receptors and has excellent bioavailability following subcutaneous administration in 
rats. 
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Figure 7. Indole derivatives used for treatment of migraine. 
 
It has been suggested that affinity for 5-HT1D receptors may be obtained by 
combining the ethylamine and indole groups. Maintenance of the hydrogen bond 
acceptor qualities of substituents in the 5-position should conserve affinity.34  
Melatonin 18 is the principal hormone of the vertebrate pineal gland.35 Recent studies 
on the pharmacology of 18 and on the distribution of its binding sites suggest that this 
neurohormone has a variety of biological effects.36, 37 Physiological roles of melatonin 
are summarized in Figure 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Pharmacological profile of melatonin 18. 
 
Protein kinase C (PKC) is of particular interest due to its involvement in cell 
differentiation, proliferation, secretory processes and gene expression 44-47 and is an 
actively exploited target for the treatment of diseases such as cancer, inflammatory 
arthritis, asthma and viral infection.48 Several natural products such as staurosporine 
19 49 are non-specific PKC inhibitors and potent indole derivatives have been 
synthezised in several laboratories. Some of these structures are illustrated in Figure 
9. The structural complexity has been reduced by omitting the chiral centers present in 
staurosporine. Also the amide group has been replaced by imide group. All these 
potent derivatives have similar features to staurosporine also. The indole moiety and 
aminopropyl chains are still discernible in their structures.  
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Figure 9. Potent indole based PKC inhibitors. 
 
Thousands of indole containing pharmaceuticals exists in the literature and some of 
the most recent ones are collected in Figure 10. SB 242784 24 has been developed for 
the treatment of osteoporosis.50 The antiemetics Ramosetron 25 and Dolasetron 26 
have potential for the treatment of chemotherapy-induced nausea and vomiting. 
Delavirdine mesylate 27 is a new HIV-1 reverse transcriptase inhibitor and Sertindole 
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28 is a neuroleptic for acute and chronic schizophrenia. Fluvastatin 29 is an HMG-
CoA reductase inhibitor and Zafirlukast 30 is a new antiasthma drug.51 
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Figure 10. Some recent indole-containing drugs. 
 
 
1.4. History of indole synthesis 
 
Indole was first prepared synthetically in 1866 by von Baeyer.52 He oxidized indigo 
31 to obtain isatin 32, reduced the isatin to oxindole 33 using zinc dust, and further 
reduced oxindole to indole 1 by passing its vapors over hot zinc oxide ( Scheme 1 ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. First indole synthesis. 
 
More generally applicable synthesis of indole derivatives involve ring closure to form 
the pyrrole ring of indole. In 1883 Fischer and Jourdan reported the first indolization 
of an arylhydrazone.53 Pyruvic acid 1-methylphenylhydrazone 34 was heated in 
ethanolic hydrogen chloride yielding 1-methylindole-2-carboxylic acid 35. However, 
it was not until the following year that Fischer and Hess identified the structure of 
35.54 
 
 
 
 
 
 
 
Scheme 2. Fischer indolization. 
 
Since this discovery the reaction has been the subject of much experimental work and 
is still one of the most versatile methods for the preparation of indoles. For example, 
sumatriptan 12 and related compounds have been prepared by this method.55 The 
mechanism proceeds through an initial acid-catalyzed tautomerization of an N-
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arylhydrazone to an enehydrazine. The enehydrazine then undergoes [3, 3]-
sigmatropic rearrangement to produce a bis-imine intermediate. Subsequent 
aromatization of the aniline ring followed by intramolecular nucleophilic attack 
produces an aminal, which after loss of ammonia affords the indole product.56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Mechanism of the Fischer indole synthesis. 
 
Some recent examples of the Fischer indole synthesis involve the use of 
montmorillonite clay and ZnCl2 in microwave conditions 57 and the use of a “masked” 
hydrazine (40).58 (Scheme 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Some recent examples of the Fischer indolizations. 
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One of the highlights in organic synthesis is the total synthesis of strychnine 45 
presented by Woodward 59 in 1954. Fischer indolization was the first step in this 
remarkable milestone of organic synthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Fischer indole synthesis as a part of the total synthesis of strychnine. 
 
Even though the Fischer indole synthesis is still one of the most important routes to 
indoles myriad other cyclization reactions have been reported including Leimgruber-
Batcho synthesis, Madelung synthesis, Bischler synthesis, Bartoli synthesis, Gassman 
synthesis and palladium-catalyzed cyclizations. These and other indole cyclization 
reactions have been reviewed elsewhere.60-62 Only those reactions, which have been 
adopted to solid phase, will be discussed later in chapter 2. The Fischer indole 
synthesis has been discussed in detailed because it was the only used cyclization 
reaction in this thesis. 
 
 
 
1.5. Solid phase chemistry 
 
Solid phase techniques have become a routine in modern organic chemistry.63 These 
techniques often employ polymeric supports to immobilize either the substrate or the 
reagent in order to simplify compound manipulation and purification. Insoluble 
polymer resins are most commonly used for such applications,64 but soluble polymers 
have also proven useful.65 The insoluble polymer resin was originally introduced by 
Merrifield in 1963,66 and that revolutionized the peptide synthesis for which he 
received the 1984 Nobel prize in chemistry. The solid-phase peptide synthesis (SPPS) 
developed by Merrifield is illustrated in Scheme 6. 
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Scheme 6. Solid-phase peptide synthesis. 
 
Reaction sequences are as follows. 1. Protected amino acid (AA1) is attached to an 
insoluble polymer via an ester bond. The polymer is filtered from solution and excess 
reagents are washed. 2. Deprotection of the first amino acid. 3. Coupling of the 
second protected amino acid (AA2-prot) via an amide bond. 4. Deprotection of the 
second amino acid. 5. Coupling of the third amino acid or cleavage of peptide AA1-
AA2. 6. Deprotection of the third amino acid. 7. Coupling of protected amino acid 
Aan-prot. or cleavage of peptide AA1-AA2-AA3. 8. Deprotection of amino acid Aan. 
9. Cleavage of the peptide AA1-AA2-AA3-Aan. 
 
In the original Merrifields peptide synthesis a polystyrene-based polymer was used as 
the solid support in which some of the benzene rings were substituted by 
chloromethyl-groups (Figure 11). 
 
 
 
 
 
 
 
 
 
 
Figure 11. Chloromethylated polystyrene. 
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The protecting group utilized in the synthesis was t-butoxycarbonyl group referred to 
as Boc. Deprotection was achieved with trifluoroacetic acid. This kind of peptide 
synthesis could be referred to as Boc-peptide synthesis. At present time the most 
common protecting group is fluorenylmethoxycarbonyl group (Fmoc). Nowadays the 
peptide synthesis is carried on by automated robots and this base sensitive group is 
more convenient to use in automated systems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Boc-protected-  and Fmoc-protected (S)-tryptophan. 
 
Solid phase chemistry was initially almost exclusively devoted to peptide synthesis. 
However, in 1970s solid phase techniques were adopted towards small organic 
molecule synthesis by pioneering works of Leznoff, Camps, Frèchet and Rapoport,67  
and more challenging chemistry is now being carried out routinely on solid phase.68 
Much research has been directed toward optimization of tailored linker groups for 
different functional group attachment.69, 70 Also the flexibility of the resins have been 
improved by incorporation of flexible cross-inkers.71 The hydrophobic nature of 
polystyrene was initially a problem, but new materials have solved this drawback and 
at present it is possible to carry out solid phase reactions even in water.72, 73 
2-Chlorotrityl-Cl-resin 48 is an acid labile resin and it has been used to immobilize 
alcohols,74 carboxylic acids,75 amines 76 and hydroxylamines.77 Carboxypolystyrene 
49 is a base labile resin and suitable to immobilize amines 78 and alcohols.79 DL-α, β-
isopropylideneglycerol resin 50 has been used to immobilize aldehydes after 
hydrolysis of the acetal.80 O- (2-Hydroxyethyl) penta (oxyethylene) polymer 51  
(HypoGel) is a hydrophilic polystyrene gel-type resin and can be used in aqueous 
solvents.81 Silica based hydroxypropyl resin 52 has also been developed for use with a 
variety of solvents, thereby countering the problem posed by swelling.82 Rink amine 
resin 53 is one of the most widely used resins in solid phase chemistry. The resin is 
most often used in the construction of carboxyamides.83 3-Hydroxymethyl-4-
nitrophenoxymethylpolystyrene 54 is an example of a photolabile resin. The acids 
could be cleaved from the resin with exposure of light. The linker is stable towards 
strong acids (Figure 13).84  
An example of more exotic resin is the traceless silicon linker resin 55. Most linkers 
leave a residue attached to the cleaved molecule; that is the functional group or a 
derivative thereof used to attach the molecule to the linker. Linkers that leave no 
obvious residue on the cleaved molecule are called traceless linkers. Shortly traceless 
linker could be defined as one where a new carbon-hydrogen bond is formed at the 
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linkage site of the cleaved molecule. Lithiated aromatic species can be attached to the 
resin affording 56. After synthetic modifications the pyridine based tricyclics could be 
cleaved with TBAF in a traceless manner (Scheme 7).85  
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 13. Resins used in solid phase chemistry. 
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Scheme 7. Traceless silicon linker attachment and cleavage. 
2.  Modification of indole structure on solid phase 
 
This chapter is a review of the synthetic solid phase approaches toward indoles and 
their analogues to be found in the literature. The first part describes the methods for 
the preparation of the indole core on solid phase. The second part covers the 
circumstances where the readily available indole core has been attached to a solid 
phase and the ring substituents have been modified. The latter part describes also 
methods for direct functionalization of polymer bound indole skeleton. 
 
2.1. Preparation of the indole core on solid phase 
 
2.2.1. Fischer cyclization on solid phase 
 
On solid phase, the Fischer indole synthesis was first adapted by Hutchins and 
Chapman.86 The synthetic route involved the use of support bound 4-benzoylbutyric 
acid 57 and a variety of substituted phenylhydrazine hydrochlorides as starting 
materials. Since the indole cyclization required acid catalysis, a base labile linker was 
chosen for the preparation of 2-arylindoles 58 (Scheme 8). Although the purity of the 
cleaved indoles was high, the overall yields remained moderate. This group has also 
adopted this method to dendrimer supports.87 Later, Cheng and Chapman 88 described 
a method for the solid phase synthesis of spiro indolines using the Fischer indole 
reaction.  
       Only a few methods have been developed for the utilization of the Fischer indole 
synthesis on solid phase. It is therefore anticipated that the method will be further 
developed and more efficiently transferred to the polymer matrix within the next few 
years making it more suitable for combinatorial chemistry purposes. 
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Scheme 8. Fischer indolization on solid phase. 
2.1.2. Palladium-catalyzed cyclization on solid phase 
 
       Methods for the aromatic substitution based on catalysis by transition metals, mainly 
palladium, have proven to be efficient approaches towards indoles on solid phase. In 
the intramolecular Heck reaction an o-halo-N-allylaniline is efficiently cyclized to 
yield the indole in good yield and high purity.  This versatile method has been reported 
in several papers. Yun and Mohan 89 described the intramolecular Heck reaction of 
polymer-bound aryl halides 59 and similar approach was later published by 
Balasubramaniam et al. 90 for 2-oxindoles. Instead of coupling the aryl moiety to the 
solid phase Zhang et al.91 immobilized the γ-bromocrotonic acid and thus obtained the 
amide 63 (Scheme 9). 
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Scheme 9. Heck reactions on solid phase. 
 
       In all these papers, the efficiency of the cyclization was demonstrated by the use of 
different starting materials. The palladium-mediated intramolecular heteroannulation 
has also proved to be a valuable method for the synthesis of the indole moiety on solid 
phase. New carbon-carbon bonds are created through a palladium-catalyzed addition 
of acetylenes to o-iodoanilines. Recent examples include the work by Bedeschi et al.92 
where 2-substituted indoles could be obtained in the reaction between resin attached o-
iodoaniline 66 and a terminal alkyne. Zhang et al. 93 and Smith et al. 94 developed this 
methodology suitable for internal alkynes and also Collini and Ellingboe 95 reported a 
solid phase synthesis of indoles with three independently variable components. Zhang 
et al. 96 and Schultz et al. 97 have also demonstrated that a palladium-mediated 
heteroannulation of terminal alkynes can be performed using a traceless sulfonamide 
linker (Scheme 10). The catalytic cycle of this reaction is presented in Scheme 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10. Indoles from resin-bound o-iodoanilines. 
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Scheme 11. Catalytic cycle of palladium-catalyzed addition of acetylenes o-
iodoanilines. 
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       Recently, a palladium catalyzed cyclization of a β-(2-halophenyl) amino-substituted α, 
β-unsaturated ester 72 was found to be effective for the solid phase synthesis of indole 
3-carboxylates 73.98 The polymer-bound enaminoester was synthesized by acid 
catalyzed condensation or by palladium(II) chloride catalyzed oxidative amination  
(Scheme 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12. Solid-phase synthesis of indole 3-carboxylates. 
 
While these methods are of great importance, a drawback is the requirement of a 
bifunctional precursor for the formation of a new C-C and C-N bond. This means that, 
in order to prepare an indole with one substituent on the aromatic ring, one must 
employ an aromatic precursor with three substituents. There are only a limited number 
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of commercially available highly functionalized aromatic compounds and time 
consuming extra work is often needed to prepare the benzenoid starting materials. 
 
 
 
2.1.3. Madelung cyclization and intramolecular Wittig reaction 
 
Wacker and Kasireddy 99 have utilized the modified Madelung indole synthesis 
successfully on solid phase. 2, 3-Disubstituted indoles were obtained in excellent 
yields and purities. Bal-resin 74 was functionalised by reductive amination followed 
by acylation, cyclization and acid promoted cleavage (Scheme 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 13. Madelung synthesis. 
 
 
 
 
 
 
 
A variation of the Madelung cyclization involves installing a functional group in the 
benzenoid precursor, which can facilitate the cyclization. Such a group is for example 
a triphenylphosphonium substituent that converts the reaction into an intramolecular 
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Wittig condensation. The required phosphonium salts 81 can be prepared from an o-
nitrobenzyl chloride or bromide. Hughes 100 utilized the phosphonium group as a 
traceless linker for the solid-phase synthesis of indole 82 on solid phase in 78% yield. 
An advantage is that the phosphine oxide by-product remains bound to the polymer 
and could be separated simply by filtration (Scheme 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 14. Intramolecular Wittig reaction in synthesis of indoles. 
 
2.1.4. Solid phase Nenitzescu indole synthesis 
 
       5-hydroxyindole derivatives can be synthesized by condensation of p-benzoquinone 
with β-aminocrotonic esters. Since many important natural products and molecules 
possess the 5-hydroxyindole-skeleton, the recent discovery of the solid-phase version 
by Ketcha et al. 101 gave a new tool to be used in the combinatorial preparation of 5-
hydroxyindole-3-carboxamides. The solid phase process involved sequential 
acetoacylation, condensation with primary amines, addition of 1,4-benzoquinones and 
cleavage by TFA (Scheme 15). 
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Scheme 15. Nenitzescu reaction on solid phase. 
 
2.1.5. Other intramolecular cyclizations giving the indole or structurally 
          closely related core 
 
       Other methods for the preparation of indoles and indole-analogues include the 
preparation of 1-hydroxy-6-indolecarboxylic acids 90.102 The compounds were 
obtained by treatment of Wang resin bound 4-fluoro-3-nitrobenzoic acid 88 with 1,3-
dicarbonyl compounds, followed by reduction and cleavage. Reductive cleavage of the 
N-O bond was attempted but was not successful (Scheme 16). 
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Scheme 16. Preparation of 1-hydroxy-indole analogues. 
 
Nicolaou et al. 103 have described a highly efficient method for the solid phase 
synthesis of substituted indoline scaffolds. Substituted o-allyl anilines were 
cycloadded onto selenenyl bromide resin 92. Resin-bound indoline scaffold 93 was 
further elaborated and cleaved tracelessly (Scheme 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 17. Traceless indoline synthesis. 
 
Recently, Hartley utilized titanium(IV)benzylidene reagents that allow traceless solid-
phase synthesis of indoles.104 Resin-bound esters 96 were reacted with titanium 
benzylidene, and thus converted to acid labile enol ether 97. Deprotection of the 
nucleophile leads to the formation of oxonium ion 99 and release of the indole from 
the resin 100. 
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Scheme 18. Indoles from titanium benzylidenes. 
 
2.2. Modification of substituents on the indole ring 
 
This part of the thesis covers circumstances where indole moieties are already 
adorned with suitable substituents before attachment to the solid phase. 
 
2.2.1. Palladium-catalyzed modifications of the indole ring 
 
As in the case of cyclizations, also in the case of the ring modifications palladium 
plays an important role. Organoboronic acids, stannanes, halides and palladium 
reagents are commercially available and the coupling reactions are among the most 
studied reactions on solid phase. Also the indole structure has been modified by these 
reactions. Smith et al. 105 successfully utilized Suzuki- and Stille-couplings in their 
discovery of a novel, high-affinity h5-HT2A antagonist. In this small series of 2-aryl 
tryptamines 102, the starting indole 101 was tethered to a Wang-carbamate linker. 
Traceless PS-TsCl (polystyrene sulfonyl chloride) linkage was used by Schultz et al.97 
when they modified the indole C-5 position by Sonogashira-, and Suzuki-couplings. 
Both above methods are based on the couplings where the electrophilic component 
(halide) is attached to solid phase. The only example where nucleophilic species 106 
(stannane) is polymer bound has been reported by Gmeiner  et al.106 Their linking 
strategy was also traceless and based on transacetalization of diethoxymethyl (DEM) 
protected indoles (Scheme 19). 
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 Zhang et al. 93 introduced a halo substituent to the indole core by conversion of a 
trimethylsilyl-group to bromo or iodo groups and they also mentioned organometallic 
coupling reactions. However no description of these reactions were mentioned 
(Scheme 20). 
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Scheme 19. Palladium-catalyzed modifications. 
 
 
 
 
 
 
 
 
 
Scheme 20. Conversion of trimethylsilyl-group to halo-groups. 
 
2.2.2. Modifications leading to tertiary amines 
 
Gmeiner et al. 107 modified the indole 2-position by treating the polymer bound 2-
chloromethylindoles 110 with arylpiperazines (Scheme 21). The compounds obtained 
were highly selective dopamine D4 receptor partial agonists. Smith et al. reported the 
use of polymer bound triflates 112 in the preparation of tertiary amines (Scheme 
21).105 
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Scheme 21. Preparation of tertiary amines. 
 
Herget et al. 108 utilized the reductive amination in the preparation of a Teleocidin 
library. In this case only aliphatic aldehydes were used (Scheme 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 22. Reductive amination on solid phase. 
 
2.2.3. Modification leading to amides 
 
Despite the fact that solid phase peptide synthesis has appeared in the literature over 
four decades only one example where the indole nucleus has been modified by amino 
acids exists. Zhang et al. 91 modified the 5-position of the resin bound carboxyindole 
116. A minilibrary of 18 compounds was prepared and an uncommon methyl ester 
hydrolysis was utilized in this solid supported library synthesis (Scheme 23). 
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Scheme 23. Modification of 5-carboxyindole derivative. 
2.3. Direct functionalization of the indole ring 
 
This chapter describes methods for direct ring substitution when the indole skeleton 
has already been attached to a polymer. Methods are introduced in numerical order of 
the substituents. 
 
2.3.1. Modification of indoles by substitution at nitrogen 
 
Procedures for N-1 substitution involve normally a base-catalyzed nucleophilic 
substitution. The strong bases usually needed for deprotonation create some 
difficulties in solid-phase chemistry. Substituents should be tolerant under highly 
basic conditions and also the linker must be compatible. In fact, the only reported 
modifications on solid-phase are alkylations.91, 95, 109 Deprotonation has been 
performed by NaH or t-BuOK and alkyl bromides have been used as electrophiles. 
One post-cleavage methylation has also been reported (Scheme 24).97 
On the other hand, palladium-catalyzed 110, 111 or copper-catalyzed 112 N-arylations 
reported in solution phase have not been reported on solid phase so far. Maybe in the 
future these reactions will be adopted to solid phase chemistry and also alkylations or 
acylations with groups that have a directing effect toward C-2 lithiation. 
 
 
2.3.2. Modification of the 2-position by Pictet-Spengler reaction 
 
The β-carboline skeleton is a key structural motif common to a large number of 
tryptophan derived alkaloids. Pictet-Spengler cyclization gives access to this class of 
compounds and this reaction has been well studied in solid phase chemistry. 113-116 
Both acid-113, 114 and base-labile 115, 116 linkers have been used to obtain the desired 
products. A variety of commercially available substituted aryl aldehydes, aliphatic 
aldehydes and ketones are viable substrates and thus allow the preparation of large β-
carboline compound libraries (Scheme 25). Recently Grigg et al. 117 reported a five 
component solid supported procedure where they utilized cycloaddition attachment, 
Pictet-Spengler reaction and finally Pd(0)-catalyzed reactions (131 ➜ 134) (Scheme 
26). 
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Scheme 24. Solid phase N-alkylations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 25. Pictet-Spengler reaction on solid phase. 
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Scheme 26. Pictet-Spengler reaction on solid phase. 
 
2.3.3. Indole 3-position modifications 
 
There are a number of methods for introducing substituents at the C-3 since this is the 
preferred site for electrophilic substitution. Most of the direct functionalizations on 
solid phase chemistry have focused on that position. The first published 
functionalization utilized the Mannich reaction as presented by Zhang et al.109 Resin 
bound (Rink amide resin) 5- and 6-carboxyindoles 135 were subjected to Mannich 
reaction with formaldehyde and a secondary amine in the presence of acetic acid. The 
obtained gramines 136 were further modified by nucleophilic substitutions with KCN 
and 2-nitroacetate. Different reaction conditions for solid phase Mannich reaction 
have been reported by Gmeiner et al.106 Dimethylmethyleneimmonium chloride 
(Böhme’s salt) was used in order to avoid acidic aqueous conditions (Scheme 27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
H
N
O
H
P
Me2NH, HCHO
AcOH, dioxane
P
N
H
N
O
H
N
2-nitroacetate
toluene
N
H
N
O
H
CN
P
N
H
N
O
H
CO2Et
NO2P
N
NC
O
O
O
P P
[(CH3)2NCH2]Cl
DMF N
NC
O
O
O
N
KCN
DMF/H2O
135 136
137
138
139 140
 36
 
 
 
 
Scheme 27. Mannich reaction. 
 
Synthetically versatile resin-bound 3-indolylmercury specie 142 was recently reported 
by Zhang et al.96 Solid supported indole was treated with mercury(II)acetate, catalytic 
amount of HClO4 and NaCl in AcOH/dioxane followed by palladium mediated 
coupling with methyl acrylate (Scheme 28). 
Solid phase acylation of indoles at C-3 by Friedel-Crafts reaction has been 
demonstrated by Schultz et al. 97 in their synthesis of 2,3,5-trisubstituted indoles. 
Aromatic acid chlorides were found to be most reactive in this AlCl3 catalyzed 
reaction (Scheme 29). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 28. Solid phase mercuration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 29. Friedel-Crafts acylation. 
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2.3.4. Functionalization of other positions 
 
The only published method for direct functionalization of the benzenoid ring on solid 
phase has been reported by Herget et al.108 In their solid phase synthesis of teleocidin 
analogues a functionality at C-7 was needed. A regioselective iodination was 
performed with iodine in pyridine/dioxane at 0oC. The resulting iodides were 
subjected to Sonogashira coupling with acetylenes on the polymeric support (Scheme 
30). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 30. Modification of 4-position by halogenation. 
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Despite the fact that pharmaceutical industry worldwide is utilizing solid-phase 
chemistry routinely, in Finland this technology is quite new. Although some small 
pharmaceutical companies are using solid supported techniques, in academia the 
research has been focused mainly on solid phase peptide synthesis. The aim of this 
study was therefore to develop solid phase chemistry techniques suitable for the 
preparation of small-molecule libraries. The fact that indole moiety is present in many 
pharmaceutical substances, gave me the reason to choose carboxyindoles as target 
molecules for my investigations in the field. I decided to modify the carboxyindoles 
by functional group transformations and by direct functionalizations. 
The specific aims of the work described here are as following: 
 
1. Preparation of 5-substituted 2-carboxyindoles on solid support (I). 
2. Bromination of different 2-carboxyindoles on solid phase (II). 
3. Vilsmeier formylation of 2-carboxyindoles on solid phase (III). 
4. Directed lithiation of polymer-bound carboxyindoles (IV). 
 
 
4. Results and Discussion 
 
4.1. Synthesis of 5-substituted 2-carboxyindoles (I) 
 
The basic structure of the target molecule 154 and retrosynthetic analysis is shown in 
Scheme 31.  
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Scheme 31. Retrosynthetic analysis of the target molecule 154. 
 
5-nitro-2-carboxyindole 149 was synthezised either from 4-nitroaniline 155 by a Japp-
Klingemann reaction 118 followed by Fischer indolization 119 or from commercially 
available 4-nitrophenylhydrazine 157. In the former case the hydrazone 158 was 
obtained in 75 % yield and in the latter case in 80 % yield after recrystallization from 
EtOH. Polyphosphoric acid (PPA) was found to be efficient reaction medium for 
cyclization to the indole 159. Indolization occurred smoothly at 80 oC and there was 
no need to heat the reaction mixture to 130 oC as reported earlier.119 The yield of 
ethyl-5-nitro-2-indolecarboxylate 159 was 83 %. Hydrolysis of 159 with LiOH in 
THF/H2O gave 149 in quantitative yield. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 32. Synthetic routes to 149. 
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carboxyindole was also found to be quite unstable. So we decided to perform the 
reduction on solid phase. Because we needed the acid functionality to the 2-position at 
the end we chose an acid-labile Wang resin 160 as a solid support. The solid phase 
procedure is described in Scheme 33. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 33. Solid phase synthesis of compounds type 154. 
 
Indole 149 was attached to the polymer 160 using 1-(2-mesitylene-sulfonyl)-3-nitro-1, 
2, 4-triazole (MSNT) and N-methylimidazole (NMI) in dichloromethane.120 The 
attachment was monitored by IR and characteristic bands at 1350 cm-1 (NO2) and 
1700 cm-1 were observed. The nitro-group was reduced with SnCl2*2H2O in DMF.121 
The conversion was checked by IR (disappearence of band at 1350 cm-1) and by the 
Kaiser test.122 In the first diversity step a reductive amination with aromatic aldehydes 
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in the presence of sodium cyanoborohydride in AcOH/DMA was performed.123 A 
further alkylation with benzylic bromides in the precence of DBU was performed thus 
providing the second diversity step.123 Cleavage using the standard TFA/DCM 
method produced the final products, which were purified by preparative TLC 
(CHCl3/EtOAc 1:1+1% AcOH). The used monomers, (aldehydes and 
benzylbromides) products and yields are summarized in Table 1. 
 
 
Table 1. Starting materials, products and yields summarized. 
 
 
  Aldehydes Ar              Benzylbromides Ar’                  Product              Yield ( % ) a 
 
 
 
 
 
 
 
 
 
 
 
X = CF3, Y = H             X = OMe, W = NO2                  154a                      51 % 
                                      Y = Z = H 
 
X = NO2, Y = H            W = NO2                                   154b                      73 % 
                                       X = Y = Z = H 
 
X = H, Y = Me              X = Y = Z = W = H                  154c                      55 % 
 
X = OMe, Y = H           W = NO2                                   154d                     69 % 
                                       X = Y = Z = H 
 
X = Cl, Y = H                W = NO2                                  154e                      74 % 
                                        X = Y = Z = H 
 
X = H, Y = NO2             X = NO2, Y = H                       154f                       40 % 
                                        Z = W = OMe 
 
                
 
                                                                                        154g                      60 % 
 
 
 
 
 
 
                                                                                       154h                      45 %       
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a Isolated purified yield ( calculated based on the commercially announced loading ). 
 
This procedure was also performed on Merrifield resin. Attachment and cleavage 
were performed according to Frenette and Friesen.124 The cesium salt of 149 was 
attached to chloromethylated polystyrene, reaction steps were performed in similar 
manner and cleavage was effected by transesterification. We noticed also that 
NaCNBH3 could be replaced by sodium acetoxyborohydride, which was also more 
convenient to use. 
In summary, we demonstrated that starting from a simple precursor 149 a diverse set 
of compounds could be synthezised in an easy manner. 
 
 
4.2. Bromination of 2-carboxyindoles on solid phase (II) 
 
Reactions performed on solid support usually involve quite simple reactions. Usually 
the reactions involve readily installed functional group transformations similar to our 
route from 150 to 154. However, solid phase reactions where some new functionality 
is installed selectively to resin-bound aromatic molecule are rare. Reactions where 
this kind of transformation is performed can be named as “ direct functionalization “ 
according to Ganesan et al.125 Ganesan et al. modified resin-bound tiophene- and 
furan derivatives by directed lithiation. Recently, Han et al. presented the introduction 
of bromine onto polymer supported thiophene.126 Solid phase iodination of phenols 
has been reported by Arsequell et al. 127, 128 
We decided to attempt selective 3-position solid-phase bromination of resin-bound 2-
carboxyindoles. The bromination targets are presented in Scheme 34. 
 
 
 
 
 
 
 
 
 
Scheme 34. Selected indole-resins. 
 
Indole-2-carboxylic acid was commercially available and 4, 6-dichloro-2-
carboxyindole was prepared similarly to 149. In solution pyridinium bromide 
perbromide (PBP) has been used successfully as a brominating agent.129 In fact, we 
tested all brominations first in solution phase before transferring them to solid phase. 
To avoid the functionalization of the resin itself we chose the simple Merrifield-resin 
as the support. In a typical procedure the starting resin was suspenced in dry pyridine 
under nitrogen and the mixture was cooled to 0 oC. PBP was dissolved in pyridine and 
added dropwise to the slurry with syringe. The mixture was stirred for 4 h at 0 oC 
before resin filtration and washing. Cleavage and analysis showed quantitative 
conversion. The brominated resin-bound indoles 163-165 where thereafter subjected 
to Suzuki coupling reaction 124 summarized in Scheme 36 and Table 2. The Suzuki 
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reaction is a palladium-catalyzed cross-coupling reaction between an organoboron 
reagent and an organohalide or triflate.132 A Growing number of organoboron 
reagents, mainly arylboronic acids, are commercially available and these compounds 
are stable and easy to handle. Those reagents are not toxic and therefore, for a large 
scale setting, a Suzuki coupling is an attractive choice. The general catalytic cycle for 
cross-coupling is presented in Scheme 35. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 35. Catalytic cycle of Pd-catalyzed coupling reactions. 
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Scheme 36. Synthetic route. 
 
Table 2. Starting materials, products and yields summarized. 
 
 Starting polymer                       ArB(OH)2                              Product        Yield a                   
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                                                                                                     167b              97 % 
 
 
 
 
 
                                                                                                    168a              96 %       
 
 
 
 
 
                                                                                                    168b             98 % 
 
 
 
 
 
                                                                                                    168c             97 % 
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a Isolated yields after column chromatography. 
The catalyst used in our experiments was tetrakis(triphenylphosphine)palladium, 
which is represented as Pd(0). In the first step polymer-bound haloindole (RX) 
undergoes an oxidative addition to Pd(0) affording intermediate R-Pd(II)-X. The next 
step is a transmetallation step with arylboronic acid (R’M). Intermediate R-Pd(II)-R’ 
undergoes reductive elimination step yielding the coupling products R-R’. Oxidative 
addition is often the rate-determining step in the catalytic cycle.130 Arylhalides 
activated by electron-withdrawing groups are known to be more reactive to the 
oxidative addition. This could be the reason for higher yields when the resin-bound 
electrophile had substituents (see Table 2). For resins 164 and 165 the reaction went 
to completion in 16 h, but for the resin 163 even the prolonged reaction time 48 h did 
not increase the yields. We didn’t try to optimize the yields in other ways because we 
had achieved our main purpose, the selective bromination on solid-phase. In fact, 
Mederski et al. 112 have reported quite comparable yields in their coupling studies in 
solution. 
 In summary, we have shown that bromination could be done selectively on solid 
phase. Of course the same limitations for selectivity exist on solid phase as in 
solution, but choosing a simple polymer with no special linkers, which could make 
the polymer itself prone to functionalizations, the aromatic functionalizations could be 
done on solid support. 
 
4.3. Vilsmeier formylation on solid-phase (III) 
 
Vilsmeier is a classical organic name reaction invented by Anton Vilsmeier in 
1927.131 The reaction is a useful variant of the Friedel-Crafts acylation and introduces 
an aldehyde functionality to aromatic molecules. Although the reaction was first used 
only for activated aromatics and heteroaromatics, it has recently also shown its 
compatibility for aliphatic substrates.132 The Vilsmeier reaction is an important 
industrial process but large quantities of phosphorus byproducts are an environmental 
problem. 
The electrophilic reagent in the Vilsmeier formylation is a chloroiminium ion 169, 
which is formed from phosphorus oxychloride and dimethylformamide as shown in 
Scheme 37.  
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Scheme 37. Formation of Vilsmeier reagent. 
 
 
The Friedel-Crafts reaction has been utilized in construction of different linker 
systems starting from polystyrene,133, 134 but only Schultz et al. 97 have used this 
acylation as direct functionalization method. We decided to try the related Vilsmeier 
reaction to provide a facile way for introducing an aldehyde group to 2-
carboxyindoles on solid phase. As in the case of the bromination studies, Merrifield 
resin was chosen as a support. The synthetic route is illustrated in Scheme 38 and the 
results are collected on Table 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 38. Vilsmeier reaction. 
 
Three different formylating salts were tested; POCl3/DMF, POCl3/NMFA and 
SOCl2/DMF. In all experiments the reaction time and equivalents of the formylating 
agent were kept constant (16 h and 10 equiv.). All reactions were run in 1, 2-
dichloroethane. Reaction worked smoothly for resins 161, 170 and 171 (quantitative 
conversion at room temperature), but for resins 150 and 162 full conversion were not 
achieved. The best conversion was achieved with POCl3/NMFA in these these 
circumstances. The results were expected because electrophilic substitutions are 
known to be more difficult in the presence of the electron withdrawing groups. In the 
case of resin 161, we also found out that two hours was enough to bring the reaction 
to completion. 
 
177, R = H
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Table 3. Attempted reaction conditions in our experiments. 
 
     Resin                Formylating agent a          Conversion ( % ) b                  T ( oC ) c 
 
      161                    POCl3/NMFA                       100                                       rt 
      161                    POCl3/DMF                          100                                       60 
      161                    POCl3/NMFA                       100                                       60 
      162                    POCl3/DMF                          15                                         60 
      162                    POCl3/NMFA                       30                                         60 
      162                    POCl3/NMFA                       90                                         reflux 
      162                    SOCl2/DMF                          10                                         60 
      150                    POCl3/DMF                          15                                         60 
      150                    POCl3/NMFA                       40                                         60 
      150                    POCl3/NMFA                       85                                         reflux 
      150                    SOCl2/DMF                          10                                         60 
      170                    POCl3/NMFA                       100                                       rt 
      170                    POCl3/DMF                          100                                       rt 
      171                    POCl3/NMFA                       100                                       rt 
      171                    POCl3/DMF                          100                                       rt 
    
aNMFA: N-methylformanilide 
bDetermined by mass percentages of isolated column-purified yields. 
cBoiling-point of 1, 2-dichloroethane (DCE) is 85 oC. 
 
To demonstrate the versatility of the obtained aldehyde functionality we prepared a 
small series of O-benzylhydroxyureas. 172 was treated with O-benzylhydroxyamine 
hydrochloride (or 4-NO2-O-benzylhydroxyamine hydrochloride) affording oxime-
ether 182a or 182b, respectively. Reduction of 182a and 182b with borane-pyridine 
complex in the presence of dichloroacetic acid 135 gave 183a and 183b. O-
benzylhydroxylamines 183a and 183b were reacted with aromatic isocyanates and 
cleaved from the resin providing O-benzylhydroxyureas 194-203. The synthesis is 
shown in Scheme 39 and yields and structures are summarized in Table 4. After each 
reaction step a small sample of resin was treated with NaOMe and the completion of 
the reactions was checked by thin-layer chromatography. The reaction times were not 
optimized. Although the overall yields of the six steps were only moderate (30-70 %, 
calculated on the basis of the commercially announced loading), the purities of the 
compounds were high (> 90 %, determined by HPLC). All products showed a single 
spot on TLC and there was no need for chromatographic purification after cleavage.  
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Scheme 39. Synthesis of O-benzylhydroxyureas. 
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Table 4. Starting materials and yields summarized. 
      Polymer                    Isocyanate                     Product                    Yield ( % ) 
 
 
 
        183a                                                                194                          67 
 
 
 
 
       183a                                                                  195                         71 
 
 
 
 
      183a                                                                   196                         30 
 
 
 
 
     183a                                                                    197                         53 
 
 
 
 
     183a                                                                    198                         70 
 
 
 
 
    183a                                                                     199                         52 
 
 
 
 
 
 
    183a and 183b                                                  200 and 201              73 and 75 
 
 
 
 
    183a and 183b                                                  202 and 203              67 and 33 
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In summary we have demonstrated that Vilsmeier formylation is an efficient and 
simple method for direct functionalization on solid phase. In the past combinatorial 
chemistry has largely focused on simple synthetic sequences, whereas the natural 
product route tends to be more complicated and creative. Combination of the solid 
phase techniques and natural product synthesis is called diversity-oriented 
synthesis.136 By using direct functionalization methods to vary the structure of 
scaffolds the diversity will go a lot further and will give an access to natural-product-
like libraries. 
 
 
 
4.4. Directed lithiation of polymer-bound carboxyindoles (IV) 
 
 
Usually the formation of 4-substituted indoles relies on the formation of the pyrrole 
ring from a suitably adorned benzenoid precursor.137 Very seldom direct 
functionalization of the 4-position can be achieved without a substituent at the 3-
position and according to our knowledge there are only two previously reported 
methods in solution.138, 139 Garibay et al. have recently published their studies on the 
directed ortho-lithiation on solid phase 140, 141 and we decided to explore this method 
in our solid phase experiments. We tried to lithiate polymer bound protected 5-
carboxyindole regioselectively at the 4-position. The precursor 206 was prepared as 
described in Scheme 40 (yield from 204 to 206 was 44 %). 
 
 
 
 
 
 
 
    
 
Scheme 40. Preparation of lithiation target. 
 
Indole 206 was tethered to aminomethylated polytetrahydrofuran cross-linked 
polystyrene (JandaJel™-NH2 resin), forming a secondary amide 207, which 
functioned as a directing metalation group. Polymer-bound indole 207 was lithiated 
with n-BuLi and quenched with benzaldehydes (see Table 5) yielding alcohols 208a-
212a and 208b-212b. After cyclative cleavage phthalides 213a-217a and 213b-217b 
were obtained in ratio 80 : 20  determined by NMR. The solid phase procedure is 
illustrated in Scheme 41. We tried to improve the regioselectivity by reducing the 
amount of n-BuLi and cooling the reaction mixture but no improvement was 
achieved. Five different aldehydes were examined and in all cases the product ratio 
was the same.  
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Scheme 41. Solid phase lithiation. 
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Table 5. Starting materials, products and yields summarized. 
 
    Aldehydes                                Products                                    Yield a ( % ) 
 
 
 
 
                                                     213a and 213b                              25  
 
 
 
 
 
 
 
                                                     214a and 214b                              23 
 
 
 
 
 
                                                     215a and 215b                              31 
       
 
 
 
 
 
 
                                                     216a and 216b                             36 
 
 
 
 
                                                     217a and 217b                            27 
 
 
 
a Isolated yield of two regioisomers based on the commercially announced loading. 
 
In summary we have demonstrated that direct functionalization, by lithiation, of 5-
carboxyindoles is possible on solid phase. Although only moderate regioselectivities 
were obtained it is obvious that directed ortho-metalation is a powerful tool for direct 
functionalization on solid phase. 
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5. Conclusions 
 
During this study, I have developed three direct functionalization methods and a 
simple method for the preparation of 5-substituted 2-carboxyindoles. These methods 
give an alternative to solid phase indole cyclizations. The brominations worked 
smoothly for all studied resin bound carboxyindoles and Suzuki-coupling could 
successfully be utilized thereafter. Combining this reaction and the 5-position 
modifications of the nitro group an additional combinatorial step could be achieved. 
The Vilsmeier formylation worked smoothly on solid phase and the obtained 
aldehyde functionality should also give many possibilities to further modify resin 
attached templates. In solid phase metalation studies of 5-carboxyindole 4-position 
functionalization was achieved in 80 % regioselectivity. Despite the moderate 
regioselectivity it is obvious that ring lithiation reactions can be adopted to solid 
phase. A wide variety of new supports with better solvent compatibility and thermal 
stability are being developed and will allow new possibilities to directly add 
functionalities to resin attached templates. Development of new functionalization 
techniques is of great importance when more complex and diverse molecule libraries 
are planned to be built on solid phase. In summary, I have shown that direct 
functionalizations are fast and simple ways to modify the indole core. In the future the 
fascinating indole core will give new challenges for both solution phase and solid 
phase organic chemists. 
 
6. Experimental 
 
1H NMR data and mass spectra data for compounds 154b-154h. 
Compound 154b: 1H NMR (400 MHz, CDCl3): δ 4. 66 (s, 2H); 4.68 (s, 2H); 6,93 (d, 
J= 2.4 Hz, 1H); 6.97 (dd, J = 9 Hz and 2.4 Hz, 1H); 7.02 (dd, J = 2.1 Hz and 0.9 Hz, 
1H); 7.30 (d, J = 8.9 Hz, 1H); 7.50 (m, 3H); 7.63 (d, J = 7.3 Hz, 1H); 8.12 (d, J = 7 
Hz, 1H); 8.18 (m, 3H); 8.70 (br, 1H). MS (ESI) m/z 445 (M-H+). 
Compound 154c: 1H NMR (400 MHz, CDCl3): δ 2.32 (s, 3H); 4.60 (s, 2H); 4.63 (s, 
2H); 6.93 (d, J = 2.4 Hz, 1H); 7.00 (m, 2H); 7.08 (m, 3H); 7.23 (m, 3H); 7.31 (m, 
4H); 8.70 (br, 1H). MS (ESI) m/z 369 (M-H+). 
Compound 154d: 1H NMR (400 MHz, CDCl3): δ 3.80 (s, 3H); 4.55 (s, 2H); 4.60 (s, 
2H); 6.86 (d, J = 8.7 Hz, 2H); 6.95 (d, J = 2.4 Hz, 1H); 7.03 (m, 2H); 7.20 ( d, J = 8.7 
Hz, 2H); 7.29 (d, J = 10 Hz, 1H); 7.46 (t, J = 7.5 Hz, 1H); 7.61 (d, J = 8.1 Hz, 1H), 
8.1 (dt, J = 8.1 Hz and 1.2 Hz, 1H); 8.16 (s, 1H); 8.70 (br, 1H). MS (ESI) m/z 430 (M-
H+). 
Compound 154e: 1H NMR (400 MHz, CDCl3): δ 4.56 (s, 2H); 4.61 (s, 2H); 6.94 (d, 
J= 2.4 Hz, 1H); 6.99 (dd, J = 9 Hz and 2.4 Hz, 1H); 7.02 (dd, J = 2.1 Hz and 0.9 Hz, 
1H); 7.22 (d, J = 8.6 Hz, 2H); 7.29 (m, 3H); 7.47 (t, J = 7.9 Hz, 1H); 7.61 (dd, J = 7.7 
Hz and 0.5 Hz, 1H); 8.10 (dt, J = 8.1 Hz and 1.2 Hz, 1H); 8.15 (s, 1H); 8.70 (br, 1H). 
MS (ESI) m/z 435 (M-H+). 
Compound 154f: 1H NMR (400 MHz, CDCl3): δ 3.75 (s, 3H); 3.96 (s, 3H); 4.73 (s, 
2H); 5.04 (s, 2H); 6.90 (m, 2H); 7.01 (dd, J = 2.1 Hz and 0.9 Hz, 1H); 7.07 (s, 1H); 
7.28 (dd, J = 10 Hz and 0.8 Hz, 1H); 7.51 (t, J = 7.9 Hz, 1H); 7.65 (d, J = 8 Hz, 1H); 
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7.76 (s, 1H); 8.13 (dt, J = 8.1 Hz and 1.2 Hz, 1H); 8.23 (s, 1H); 8.70 (br, 1H). MS 
(ESI) m/z 505 (M-H+). 
Compound 154g: 1H NMR (400 MHz, CDCl3): δ 4.47 (s, 2H); 4.63 (d, J = 1.6 Hz, 
2H); 6.27 (d, J = 3.7 Hz, 1H); 6.98 (m, 1H); 7.11 (dd, J = 2.1 Hz and 0.9 Hz, 1H); 
7.13 (d, J = 3.7 Hz, 1H); 7.20 (m, 4H); 7.33 (d, J = 8.9 Hz, 1H); 8.70 (br, 1H). MS 
(ESI) m/z 443 (M-H+). 
Compound 154h: 1H NMR (400 MHz, CDCl3): δ 4.61 (s, 2H); 4.74 (s, 2H); 6.34 (d, 
J= 3.7 Hz, 1H); 7.08 (dd, J = 2.1 Hz and 0.8 Hz, 1H); 7.11 (m, 2H); 7.20 (d, J = 3.6 
Hz, 1H); 7.33 (dd, J = 9.7 Hz and J = 0.9 Hz, 1H); 7.48 (m, 3H); 7.84 (m, 4H); 8.70 
(br, 1H). MS (ESI) m/z 440 (M-H+).  
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